Impact of Covid 19 Vaccine on Male and Female Fertility
COVID-19 Vaccine and Reproductive Health
DOI:
https://doi.org/10.69750/dmls.01.04.043Keywords:
SARS-CoV-2, COVID-19 pandemic, fertility, spike protein, ACE2 receptor, syncytin-1, COVID-19 vaccines, Pfizer-BioNTech, mRNA vaccines, reproductive healthAbstract
Background:
The COVID-19 outbreak has emerged as one of the most difficult global medical crises in a decade. SARS-CoV-2, the pathogen responsible for the disease, has contaminated more than 110 million individuals and resulted in over 2.30 million deaths worldwide within the first year of its emergence. The global scientific community has been working tirelessly to understand the virus, develop vaccines, and comprehend natural immunity.
Objective:
This review aims to explore the impact of COVID-19 on male and female fertility, with a primary focus on the mechanisms and effects of different COVID-19 vaccines on fertility.
Methodology:
We reviewed existing literature on the effects of SARS-CoV-2 on fertility and the various COVID-19 vaccines authorized for emergency use. Special emphasis was placed on the Pfizer-BioNTech, Moderna, and Johnson & Johnson–Janssen vaccines, which received emergency use approval from the U.S. Food and Drug Administration at the end of 2020 and the beginning of 2022.
Results:
The study will provide insights into the direct effects of the virus on male and female fertility and how different vaccines might influence these effects. Each vaccine has a unique mechanism of action, which may have varying implications for fertility.
Conclusion:
This review highlights the importance of understanding the interaction between COVID-19 vaccines and fertility, as this knowledge is crucial for informed decision-making regarding vaccination, particularly among individuals concerned about reproductive health. Further research is necessary to fully elucidate the long-term impacts of these vaccines on male and female fertility.
Downloads
References
Anand P, Stahel VP. The safety of Covid-19 mRNA vaccines: a review. Patient safety in surgery. 2021;15(1):20.doi: 10.1186/s13037-021-00291-9
Girardi G, Bremer AA. Scientific evidence supporting coronavirus disease 2019 (COVID-19) vaccine efficacy and safety in people planning to conceive or who are pregnant or lactating. Obstetrics & Gynecology. 2022;139(1):3-8.doi: 10.1097/AOG.0000000 000004636
Markert UR, Szekeres-Bartho J, Schleußner E. Adverse effects on female fertility from vaccination against COVID-19 unlikely. Journal of reproductive immunology. 2021;148:103428. doi:10.1016/j.jri.2021.103428
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497-506.doi:org/10.1016/S0140-6736(20)30183-5
Kadali RA, Janagama R, Peruru S, Malayala SV. Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. International Journal of Infectious Diseases. 2021;106:376-81.doi: 10.1016/j.ijid.2021.04.047
Lifshitz D, Haas J, Lebovitz O, Raviv G, Orvieto R, Aizer A. Does mRNA SARS-CoV-2 vaccine detrimentally affect male fertility, as reflected by semen analysis? Reproductive biomedicine online. 2022;44(1):145-9.doi: 10.1016/j.rbmo.2021.09.021
Joseph NT, Rasmussen SA, Jamieson DJ. The effects of COVID-19 on pregnancy and implications for reproductive medicine. Fertility and sterility. 2021;115(4):824-30.doi: org/10.1016/j.fertnstert.2020.12.032
Schaler L, Wingfield M. COVID-19 vaccine—can it affect fertility? Irish Journal of Medical Science (1971-). 2022;191(5):2185-7.doi: org/10.1007/s11845-021-02807-9
Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Coronaviruses: methods and protocols. 2015:1-23.doi: 10.1007/978-1-4939-2438-7_1
Chen P, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J, et al. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19. New England Journal of Medicine. 2021;384(3):229-37.doi: 10.1056/NEJMoa2029849
Lo NC, Bezerra FSM, Colley DG, Fleming FM, Homeida M, Kabatereine N, et al. Review of 2022 WHO guidelines on the control and elimination of schistosomiasis. The Lancet Infectious Diseases. 2022;22(11):e327-e35.doi: 10.1016/S1473-3099(22)00221-3
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. cell. 2020;181(2):271-80. e8.doi: 10.1016/j.cell.2020.02.052
Hanson SW, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. Jama. 2022;328(16):1604-15.doi: 10.1001/jama.2022.18931.
Hoffmann M, Krüger N, Schulz S, Cossmann A, Rocha C, Kempf A, et al. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell. 2022;185(3):447-56. e11.doi: 10.1016/j.cell.2021.12.032
Lo P-S, Dwivedi YK, Tan GW-H, Ooi K-B, Aw EC-X, Metri B. Why do consumers buy impulsively during live streaming? A deep learning-based dual-stage SEM-ANN analysis. Journal of Business Research. 2022;147:325-37.doi: org/10.1016/j.jbusres.2022.04.013
Dalpiaz P, Lamas A, Caliman I, Ribeiro Jr R, Abreu G, Moyses M, et al. Sex hormones promote opposite effects on ACE and ACE2 activity, hypertrophy and cardiac contractility in spontaneously hypertensive rats. PloS one. 2015;10(5):e0127515.doi: org/10.1371/journal.pone.0127515
Gao T, Yao H, Song J, Liu C, Zhu Y, Ma X, et al. Identification of medicinal plants in the family Fabaceae using a potential DNA barcode ITS2. Journal of ethnopharmacology. 2010;130 (1):116-21.doi:10.1016/j.jep.2010.04.026
Lo K-W, Lo YD, Leung S-F, Tsang Y-S, Chan LY, Johnson PJ, et al. Analysis of cell-free Epstein-Barr virus-associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clinical chemistry. 1999;45(8): 1292-4.doi: org/10.1093/clinchem/45.8.1292
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The lancet. 2020;395(10224):565-74.doi: org/10.1016/S0140-6736(20)30251-8
Magon H, Smith J, Besson J, Hau E, Taylor S, Ruben J, et al. Adapting to change: exploring perceptions and demands of the coronavirus (COVID-19) workforce changes–an Australian multi-institutional radiation oncology survey. Australian Health Review. 2024.
doi: 10.1071/AH23183.
Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, et al. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. New England Journal of Medicine. 2020;383(25):2427-38.
doi: 10.1056/NEJMoa2028436
Abuin P, Anderson A, Ferramosca A, Hernandez-Vargas EA, Gonzalez AH. Characterization of SARS-CoV-2 dynamics in the host. Annual reviews in control. 2020;50:457-68.doi: org/10.1016/j.arcontrol.2020.09.008
Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. The Lancet. 2020;396(10249):467-78.doi: 10.1016/S0140-6736(20)31604-4.
Orvieto R, Noach-Hirsh M, Segev-Zahav A, Haas J, Nahum R, Aizer A. Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle? Reproductive Biology and Endocrinology. 2021;19(1):69.doi: org/10.1186/s12958-021-00757-6
Madhi SA, Polack FP, Piedra PA, Munoz FM, Trenholme AA, Simões EA, et al. Respiratory syncytial virus vaccination during pregnancy and effects in infants. New England Journal of Medicine. 2020;383(5):426-39.doi: 10.1056/NEJMoa1908380.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New England journal of medicine. 2021;384(5):403-16.doi: 10.1056/NEJMoa2035389
Rubin EJ, Longo DL, Baden LR. Interleukin-6 receptor inhibition in Covid-19—cooling the inflammatory soup. Mass Medical Soc; 2021. p. 1564-5.doi: 10.1056/NEJMe2103108
Wang P, Casner RG, Nair MS, Wang M, Yu J, Cerutti G, et al. Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization. Cell host & microbe. 2021;29(5):747-51. e4.doi: 10.1016/j.chom.2021.04.007
Girardi G, Bremer AA. Climate and environmental changes exacerbate health disparities in pregnant people and their offspring. How can we protect women and their babies? Birth Defects Research. 2024;116(2):e2313.doi: 10.1002/bdr2.2313
Golan Y, Prahl M, Cassidy AG, Gay C, Wu AH, Jigmeddagva U, et al. COVID-19 mRNA vaccination in lactation: assessment of adverse events and vaccine related antibodies in mother-infant dyads. Frontiers in immunology. 2021;12:777103.doi: 10.3389/fimmu.2021.777103
Wang Z, Muecksch F, Schaefer-Babajew D, Finkin S, Viant C, Gaebler C, et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature. 2021;595(7867):426-31.doi: doi.org/10.1038/s41586-021-03696-9
Bertrand K, Honerkamp-Smith G, Chambers CD. Maternal and child outcomes reported by breastfeeding women following messenger RNA COVID-19 vaccination. Breastfeeding Medicine. 2021;16(9):697-701.doi: 10.1089/bfm.2021.0169
Ella R, Reddy S, Blackwelder W, Potdar V, Yadav P, Sarangi V, et al. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial. The Lancet. 2021;398(10317):2173-84.doi: org/10.1016/S0140-6736(21)02000-6
Walsh EE, Frenck Jr RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. New England Journal of Medicine. 2020;383(25):2439-50.
doi: 10.1056/NEJMoa2027906
Kim L, Garg S, O’Halloran A, Whitaker M, Pham H, Anderson EJ, et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019 (COVID-19)-associated hospitalization surveillance network (COVID-NET). Clinical infectious diseases. 2021;72(9):e206-e14.doi: 10.1093/cid/ciaa1012
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The lancet. 2021;397 (10270):220-32.doi:10.1016/S0140-6736(20)32656-8
Chen RE, Zhang X, Case JB, Winkler ES, Liu Y, VanBlargan LA, et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nature medicine. 2021;27(4):717-26.
doi: 10.1038/s41591-021-01294-w
Abdel-Moneim A. COVID-19 pandemic and male fertility: clinical manifestations and pathogenic mechanisms. Biochemistry (Moscow). 2021;86(4):389-96.doi: 10.1134/S00 06297921040015
Chaturvedi R, Lui B, Aaronson JA, White RS, Samuels JD. COVID-19 complications in males and females: recent developments. Journal of Comparative Effectiveness Research. 2022;11(9):689-98.doi: org/10.2217/cer-2022-0027
Ma L, Xie W, Li D, Shi L, Ye G, Mao Y, et al. Evaluation of sex‐related hormones and semen characteristics in reproductive‐aged male COVID‐19 patients. Journal of medical virology. 2021;93(1):456-62.doi: 10.1002/jmv.26259
Nguyen NT, Chinn J, De Ferrante M, Kirby KA, Hohmann SF, Amin A. Male gender is a predictor of higher mortality in hospitalized adults with COVID-19. PloS one. 2021;16(7):e0254066.doi:10.1371/journal .pone 0254066
Girardi G, Bremer AA. The intersection of maternal metabolic syndrome, adverse pregnancy outcomes, and future metabolic health for the mother and offspring. Metabolic syndrome and related disorders. 2022;20(5): 251-4.doi: org/10.1089/met.2021.0124
Nazir M, Asghar S, Rathore MA, Shahzad A, Shahid A, Khan AA, et al. Menstrual abnormalities after COVID-19 vaccines: A systematic review. Vacunas. 2022;23:S77-S87.doi: 10.1016/j.vacun.2022.07.001
Hale VL, Dennis PM, McBride DS, Nolting JM, Madden C, Huey D, et al. SARS-CoV-2 infection in free-ranging white-tailed deer. Nature. 2022;602(7897):481-6.doi: org/10.1038/s41586-021-04353-x
Bentov Y, Beharier O, Moav-Zafrir A, Kabessa M, Godin M, Greenfield CS, et al. Ovarian follicular function is not altered by SARS–CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination. Human Reproduction. 2021;36(9):2506-13.doi: 10.1093/humrep/deab182
Saad-Roy CM, Morris SE, Metcalf CJE, Mina MJ, Baker RE, Farrar J, et al. Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes. Science. 2021;372 (6540):363-70.doi: 10.1126/science.abg8663
Moyo-Gwete T, Madzivhandila M, Makhado Z, Ayres F, Mhlanga D, Oosthuysen B, et al. Cross-reactive neutralizing antibody responses elicited by SARS-CoV-2 501Y. V2 (B. 1.351). New England Journal of Medicine.2021;384(22): 216 1-3.doi: 10.1056/NEJMc2104192
Chen SL-S, Jen GH-H, Hsu C-Y, Yen AM-F, Lai C-C, Yeh Y-P, et al. A new approach to modeling pre-symptomatic incidence and transmission time of imported COVID-19 cases evolving with SARS-CoV-2 variants. Stochastic Environmental Research and Risk Assessment. 2023;37(1):441-52.doi:10.1007/s00477-022-02305-z
Huang H-Y, Lin Y-C-D, Li J, Huang K-Y, Shrestha S, Hong H-C, et al. miRTarBase 2020: updates to the experimentally validated microRNA–target interaction database. Nucleic acids research. 2020;48(D1):D148-D54.doi: 10.1093/nar/gkz896.
Downloads
PlumX Metrics
Published
Issue
Section
License
Copyright (c) 2024 DEVELOPMENTAL MEDICO-LIFE-SCIENCES
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/public domain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
